Alaunos Therapeutics | ZIOP - Należności Handlowe





Należności Handlowe Zmiana Data
Alaunos Therapeutics USD 2K 0 2025-06
Amgen USD 9.57B 1.08B 2025-12
AstraZeneca USD 17.88B 1.17B 2026-03
Baxter International USD 2.01B 231M 2025-12
Biogen USD 1.79B 76.6M 2026-03
Bioline Rx USD 699K 418K 2025-09
Bristol-Myers Squibb USD 14.52B 91M 2025-12
Celltrion KRW 1.51T 128.69B 2025-09
Corcept Therapeutics USD 59.79M 9.84M 2025-12
Cspc Pharmaceutical CNY 8.79B 64.64M 2025-12
Curis USD 2.55M 400K 2024-06
Deva Holding AS TRY 3.03B 343.23M 2023-09
Dianthus Therapeutics USD 52K 4.95M 2025-12
Divis Laboratories Ltd INR 26.28B 1.16B 2025-09
Gilead Sciences USD 4.91B 182M 2025-12
GlaxoSmithKline GBP 7.94B 178M 2026-03
Incyte USD 1.05B 27.09M 2026-03
Intrexon USD 1.02M 559K 2024-06
Ionis Pharmaceuticals USD 74M 8M 2026-03
J&J USD 21.33B 3.72B 2025-12
Kangmei Pharma CNY 3.15B 295.48M 2025-09
Karyopharm Therapeutics USD 26.18M 5.6M 2025-12
Knight Therapeutics CAD 183M 7.46M 2025-12
Laboratorios Farma EUR 143.38M 16.93M 2023-12
Malin Corporation EUR 500K 300K 2024-12
Medical Developments International AUD 7.48M 174K 2025-12
Merck USD 11.78B 345M 2025-12
Neuren Pharmaceuticals AUD 26.54M 5.83M 2025-12
Novartis USD 12.29B 3.3B 2025-12
Organigram Holdings CAD 49.94M 14.92M 2025-12
Ovoca Bio EUR 39K 408K 2025-06
Pfizer USD 18.12B 2.02B 2025-09
Pharma Mar EUR 60.6M 18.83M 2025-12
PTC Therapeutics USD 181.62M 21.45M 2025-12
Qiagen NV USD 402.61M 9.05M 2025-12
Regeneron Pharmaceuticals USD 5.73B 10.1M 2026-03
Roche Holding CHF 11.9B 460M 2025-12
Sangamo BioSciences USD 581K 110K 2024-06
Sartorius EUR 366.6M 74.9M 2026-03
Sino Biopharmaceutical CNY 8.45B 3.18B 2025-06
TG Therapeutics USD 265.38M 33.86M 2025-09
Tilray USD 109.07M 2M 2025-09
Verastem USD 9.01M 8.81M 2025-12
Zealand Pharma A/S 340M 94.1M 2025-12
Zz Pientze Pharmaceu CNY 1.06B 60.42M 2026-03